Ingles Markets (NASDAQ:IMKTA) kicked off its fiscal 2026 with a powerful performance on Thursday, reporting that net income soared to $28.1 million as the regional grocer successfully expanded margins and lowered interest expenses.
AllianceBernstein Holding (NYSE:AB) reported financial results for the fourth quarter and full year ended December 31, 2025, highlighted by record assets under management and margin
Xcel Energy (NASDAQ:XEL) closed a transformative fiscal 2025 on Thursday, delivering on its earnings guidance for the 21st consecutive year while simultaneously navigating a complex legal landscape in Texas and Colorado.
RBC Bearings (NYSE: RBC) delivered a significant earnings beat for its fiscal third quarter on Thursday, as a 41.5% explosion in Aerospace and Defense (A&D) revenue propelled the stock to a new 52-week high.
Nathan's Famous (NASDAQ:NATH), the iconic hot dog restaurant chain, reported financial results for its third fiscal quarter ended December 28, 2025.
Atlanta-based Marine Products (NYSE:MPX), a manufacturer of fiberglass boats under the Chaparral and Robalo brands, reported financial results for the fourth quarter and full year ended December 31, 2025.
Regis Corporation (NASDAQ:RGS) reported a sharp double-digit increase in revenue for its fiscal second quarter on Thursday, as the haircare giant reaped the rewards of its strategic pivot back to company-owned salons.
Amazon (NASDAQ:AMZN) reported strong financial results for the fourth quarter and full year ended December 31, 2025, driven by robust holiday demand, continued AWS momentum, and heavy investments in artificial intelligence infrastructure.
Reddit (NYSE:RDDT) shares surged in after-hours trading on Thursday after the social media platform delivered a "triple-beat" report, significantly outperforming Wall Street expectations on revenue, earnings, and user growth while announcing its first-ever $1 billion share repurchase program.
Telehealth leader Hims & Hers Health (NYSE:HIMS) sent shockwaves through the pharmaceutical sector on Thursday, announcing the launch of a compounded oral semaglutide pill priced significantly lower than Novo Nordisk’s brand-name Wegovy.
Sirius XM Holdings (NASDAQ:SIRI) reported a complex finish to fiscal 2025 on Thursday, as the satellite radio giant managed to edge past revenue expectations while its bottom line was severely crimped by non-cash charges and a shrinking satellite subscriber base.
Bristol Myers Squibb (NYSE:BMY) shares gained 4% on Thursday after the pharmaceutical giant reported fourth-quarter results that surpassed expectations, signaling that its "Growth Portfolio" is successfully absorbing the impact of patent expirations on legacy blockbusters.
